Treatment of Enterococcus faecalis in Urine
For uncomplicated Enterococcus faecalis urinary tract infections, ampicillin or amoxicillin-clavulanate is the first-line treatment, with nitrofurantoin as an effective alternative. 1
First-Line Treatment Options
- Ampicillin: Standard dosing based on susceptibility testing 1
- Amoxicillin-clavulanic acid: 500/125 mg orally three times daily for 7 days 1
- Nitrofurantoin: 100mg twice daily for 5 days (for uncomplicated cases) 1
Alternative Treatment Options
- Trimethoprim-sulfamethoxazole: 160/800 mg twice daily for 3-7 days 1
- Fosfomycin: 3g single dose (particularly effective for uncomplicated UTIs) 1
- Fluoroquinolones (ciprofloxacin or levofloxacin): Consider only if susceptibility confirmed due to increasing resistance rates 1
For Resistant Strains
Penicillin-Resistant Strains
- Vancomycin: 30 mg/kg per 24h IV in 2 equally divided doses 2
- Plus Gentamicin: 3 mg/kg per 24h IV or IM in 3 equally divided doses 2
High-Level Aminoglycoside Resistant Strains
- Ampicillin + Ceftriaxone: This synergistic combination is effective for high-level aminoglycoside-resistant strains 1, 3
- Ampicillin 2g IV every 4 hours
- Ceftriaxone 2g IV every 12 hours
Multidrug-Resistant Strains
- Daptomycin: Shown to be active against Enterococcus faecalis, including vancomycin-resistant isolates 4
- Linezolid: Consider for resistant strains but monitor for toxicity 1
Treatment Duration
- Uncomplicated infections: 5-7 days 1
- Complicated infections: 10-14 days 1
- Pyelonephritis or severe infections: 14 days 1
Important Considerations
Avoid cephalosporins as monotherapy: Enterococci have minimal or no susceptibility to most cephalosporins when used alone 1
Renal function adjustment:
- Nitrofurantoin should be avoided in patients with creatinine clearance <30 mL/min 1
- Adjust aminoglycoside dosing based on renal function and drug levels
Synergistic combinations:
Susceptibility testing: Always obtain antimicrobial susceptibility testing to guide therapy, as resistance patterns vary 1
Pitfalls to Avoid
- Monotherapy failure: E. faecalis is partially resistant to many antimicrobials, leading to treatment failures with monotherapy in serious infections 5
- Aminoglycoside toxicity: Consider alternatives to aminoglycosides in patients with renal impairment or at risk for nephrotoxicity 3
- Inadequate duration: Short treatment courses may lead to relapses, particularly in complicated infections 6
- Fluoroquinolone resistance: High rates of resistance make fluoroquinolones less reliable for empiric therapy 1
By following these evidence-based recommendations, clinicians can effectively treat Enterococcus faecalis urinary tract infections while minimizing the risk of treatment failure and antimicrobial resistance.